Practical circadian therapy for the cancer patient involves 3 spheres of intervention-improving lifestyle, optimizing internal biochemical milieu, and adjusting treatment times. The potential value of improving overall circadian functioning is shown in the work of Mormont et al in which pronounced rest-activity rhythms were associated with better survival in colorectal cancer patients receiving chronomodulated chemotherapy. Lifestyle interventions that may improve circadian functioning involve diet, physical activity, and mind-body therapies. A diet that is anti-inflammatory and has appropriate carbohydrate intake, as well as regular meal timing, encourages normal circadian cycles. Adequate daytime physical activity encourages restful sleep, and morning light exposure during exercise may entrain melatonin rhythms. Meditation and other mind-body therapies can reduce anxiety and depression that may disrupt sleep. Aspects of the biochemical milieu that specifically disrupt circadian functioning are inflammation and stress hormones. Inflammation and cytokine disruption can be addressed with diet, herbs, and other natural substances. Chronomodulation of chemotherapy in a US clinical setting will be discussed. A series of 12 cases will be presented of patients who experienced grade 3 to 4 toxicities with various chemotherapy regimens for colorectal cancer. When rechallenged with the same regimens administered chronotherapeutically, none of the patients experienced grade 3 to 4 toxicity. Integrating all the above treatment modalities has the potential to improve both the quality of life and disease outcomes in cancer patients.
The systematic integrative cancer treatment model discussed here specifically addresses the combination of complementary medicine with conventional treatment. Complementary medicine includes a wide variety of therapies that involve, among others, lifestyle modification and use of dietary supplements. Circadian therapy cuts across and interacts with both conventional treatments and several aspects of complementary therapies. In this article, we will review the literature on circadian aspects of complementary therapies and will present specific strategies for implementing a lifestyle regimen sensitive to issues of circadian biology. We will also discuss the interaction of circadian biology with the internal biochemical milieu or "cancer terrain." Finally, we will present results of a small study of patients treated with chronomodulated chemotherapy in addition to a full integrative regimen and review how circadian lifestyle therapy should be adapted to the situation of patients in treatment for more advanced cancers.
The model presented here is based on work presented in a recent volume, Life Over Cancer. 1 The book arises from 3 decades of clinical work in oncology as well as more than 10 years of experience in chronomodulated chemotherapy. The model is regularly implemented with patients, along with a full integrative lifestyle regimen. A central concept of this integrative medicine model is that of the 3 spheres of intervention ( Figure 1) : lifestyle, biology, and treatment. The first sphere, lifestyle, comprises interventions in the areas of diet, exercise, and mind-body medicine. The second sphere comprises a set of factors that control cancer-relevant aspects of the internal biochemical milieu or cancer terrain. These factors, termed terrain factors in this model, include oxidation, inflammation, immunity, blood coagulation, the insulin-IGF (insulin-like growth factor) axis, and stress hormones. The terrain factors together affect many of the challenges that cancer patients face. These challenges include reducing the risk of disease progression or recurrence, supporting the efficacy of conventional treatment, promoting tolerance of conventional treatment, maintaining quality of life, and preventing life-threatening complications. The terrain factors can be modified by lifestyle, dietary supplements, and medications. They affect, and are affected by, circadian disruptions. The third sphere, treatment, comprises the interventions of conventional medicine: surgery, radiation, and chemotherapy for cancer patients. Chronomodulated chemotherapy is a major intervention in this area, but circadian lifestyle interventions specifically aimed at patients going through treatment or coping with advanced cancers are also included in the third sphere.
The ultimate goal of this integrative cancer model is to have an impact on patient survival through improvement in quality of life and the lifestyle and biology spheres. The mechanism for the model as it relates to circadian disruption is shown in Figures 2 and 3 . Circadian disruption interacts with quality of life through conditions such as fatigue, insomnia, appetite loss, depression, and nutritional deficiency. This affects the elements of the biochemical milieu, clinical complications, treatment side effects, and factors that interfere with treatment. These elements, in turn, affect the probability of disease progression or recurrence and of life-threatening complications such as pneumonia, thromboembolisms, infection, and others, which can shorten survival. This network of disruption is represented in Figure  2 . As shown in Figure 3 , integrative interventions, including circadian-sensitive lifestyle modifications, can be used to prevent or moderate the elements of the biochemical milieu, clinical complications, treatment side effects, and interference with treatment. By reducing the effects of disruption on these elements, the model proposes to reduce the risks of progression, recurrence, and complications, thereby, improving survival. Circadian rhythm disturbance in cancer patients can be profound. 2 The work of Mormont and colleagues 3 emphasizes the potentials of circadian-sensitive lifestyle intervention to improve patient outcomes. In a 2000 study of patients receiving chronomodulated therapy for colon cancer, those who had the most regular circadian rhythms as indicated by standard actigraphic parameters (I<O [ie, movement in bed versus out of bed] and autocorrelation coefficient for timing of activity levels between days) had significantly higher 2-year survival than those with the least regular rhythm. 3 These results have been confirmed by Innominato et al 4 in a 2009 multi-institutional survey of 130 previously untreated metastatic colon cancer patients receiving conventional or chronomodulated FOLFOX. This survey also validated a strong impact of regular circadian rhythm on health-related quality of life. The remainder of this article reviews the 3 spheres of intervention with emphasis on circadian impacts of disruption and circadian intervention strategies.
A small observational study of rest-activity rhythms, sleep, and quality of life was conducted among cancer patients receiving chemotherapy at the Block Center for Integrative Cancer Treatment that emphasizes the impact of functional and physical deficits caused by cancer and chemotherapy on sleep and rest-activity rhythms. This study used the SenseWear Pro-2 Armband (Bodymedia, Inc, Pittsburgh, PA) 5 and was approved by the institutional review board of the Chicago School of Professional Psychology. The armband is worn on the upper arm and comprises an accelerometer, heat flux sensor, galvanic skin response sensor, and body temperature sensors. It gives output similar to that of an accelerometer, from which the I<O variable can be calculated. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI), a subjective rating of sleep quality by the patient. Quality of life was measured by the FACT-G (Functional Assessment of Cancer Therapy-General), a patient self-report scale, which contains subscales for physical, functional, social, and emotional domains. Chemotherapy patients (predominantly breast and colon cancer, with advanced disease) were screened for use of sleep medications, chemotherapy-related medications that would have sedative effects, and supplements that induce sleep, including doses of melatonin of more than 10 mg/night. In all, 24 patients not using such medications consented to participate in the study, in which they received SenseWear Armbands at their homes by mail, timed to arrive 1 week before their next scheduled chemotherapy treatment. Patients wore the armbands for 72 hours, removing them only for showering, and returned them to the center when visiting for chemotherapy treatment. Data from the armband were downloaded to a computer and analyzed; a researcher met with each patient to review their results. Pearson correlation coefficients were calculated among the study variables. Patients for whom sleep problems were detected by the armband were referred to Center clinical staff for further evaluation.
The mean PSQI score for the 24 patients was 6.67; a typical cutoff indicating sleep problems is 8.0 (higher scores indicate more disturbed sleep). The mean FACT-G score was 83.79, and the mean I<O value was 95.42% (out of a possible 100%, with lower scores indicating more disturbed sleep). We observed a significant negative correlation between PSQI and I<O (r = 0.575; P < .01), indicating that the measurements generated by the armband were consistent with the direction anticipated: that is, worse subjective sleep quality predicted worse I<O or greater sleep disruption. Quality of life was also significantly negatively correlated with sleep quality as measured by the PSQI, with a correlation of the global FACT-G score of -.437 (P < .05). The PSQI was also strongly correlated with the FACT-G physical subscale (r = -.482; P < .05) and the FACT-G functional subscale (r = -.511; P < .05). The physical subscale deals with pain, nausea, fatigue, and treatment side effects. The functional subscale deals with sleep (which may inflate the correlation with PSQI), ability to work and to enjoy life, and acceptance of illness. However, the PSQI was not correlated with the emotional and social subscales of the FACT-G. Nor was the I<O value correlated with the FACT-G (the correlation with the physical subscale was near significance, with P < .08). An obvious limitation of this study is the small number of patients involved: with a larger sample, this correlation may have been significant.
This study indicates that circadian disruption itself did not affect the quality of life in this small, mixed group of chemotherapy patients. However, the correlation of subjective sleep quality with the global, physical and functional subscales of the FACT-G suggests a strong linkage between sleep and the physical problems associated with cancer and its treatment as well as the functional aspects of effects on work and daily living. The conditions measured in the physical subscale, in particular, may directly disturb sleep. Thus, attempts to address pain, nausea, fatigue, and side effects through lifestyle, supplement, and medical interventions may affect sleep and, ultimately, circadian rhythms, as suggested by 
Lifestyle

Lifestyle Interventions: Diet
Froy summarized the considerable animal data on diet and circadian rhythm in a 2007 review. 6 Many metabolic hormones involved in food digestion and metabolism show circadian oscillations, including insulin, glucagons, adiponectin, leptin, and ghrelin. The circadian rhythms of the metabolic system are affected both by the central circadian clock in the suprachiasmatic nucleus and by peripheral oscillators that can be reset by timing of food intake and quality of food. Table 1 shows basic recommendations for using diet to reset disrupted circadian rhythm or help strengthen normal rhythms in patients who are under stress. These guidelines apply mainly to patients with earlier-stage cancers and those who are not currently undergoing conventional surgery, radiation, or chemotherapy; guidelines for more advanced patients or those in stressful treatment regimens are discussed in the Treatment section of this review. Several aspects of Table 1 are commonly recommended to patients desiring to improve sleep, and some are consistent with general anticancer principles, but others need further discussion.
Recommended dietary composition is a low-fat diet, high in vegetables and fruit. Elevated dietary fat was observed by Kohaska et al 7 to alter circadian food consumption in mice. As the mice became obese because of their high calorie and fat intake, their eating patterns shifted: the excess caloric intake eventually all occurred during their normal sleep phase. The diet also affected functioning of clock genes and transcription factors. Modest caloric consumption and lowfat diets can help in controlling obesity, which worsens cancer prognosis as well as apparently distorting circadian rhythms. Major circadian misalignment in meal timing, comparable to shift work or jet lag, altered multiple metabolic variables in people observed under a 28-hour day circadian pattern in a controlled environment. Increased glucose and insulin, decreased leptin, a reversed cortisol rhythm, increased arterial pressure, reduced sleep efficiency, and postprandial glucose responses similar to prediabetes were observed. 8 Because food is a major zeitgeber (external time signal) for peripheral circadian oscillators, as discussed by Froy, 6 consistent and appropriately timed meals are a basic tenet of circadian-sensitive eating.
Timing of meals should also take into account circadian rhythms of metabolism. Insulin secretion, for instance, is highest between noon and 6:00 pm. 9 Night is a time of relative insulin resistance. 10 Glucose tolerance is lower in the evening; for patients with impaired glucose tolerance and type 2 diabetes, glucose tolerance is also lower in the morning than for normal individuals. 11 Serum leptin, on the other hand, is highest between midnight and 2:30 am and lowest in the early afternoon; 12 sweet taste recognition parallels the leptin rhythm. 13 Plasma triacylglycerol, the major lipid component of dietary fat in the circulation after meals, shows a circadian rhythm in response to food intake. Triacylglycerol is higher during nighttime meals, as are glucose and insulin responses to meals. 8 These observations suggest that the major meal of the day is best timed between midday and late afternoon, when insulin secretion is likely to be highest and glucose tolerance is higher. Because of the problems associated with elevated blood glucose, which is more likely during periods of low glucose tolerance, individuals with impaired glucose tolerance and diabetes should be especially careful to decrease intake of simple sugars in the morning and evening-night hours.
The timing and nature of carbohydrate intake is another dimension of circadian-sensitive dietary strategies. Highcarbohydrate diets, especially those high in simple carbohydrates, are known to be calming or even sleep-inducing. In participants kept awake for 24 hours in a metabolic ward, fed either a high-fat or a high-carbohydrate diet, the high-carbohydrate condition was associated with increased sleepiness after meals and also larger oscillations in performance throughout the day than the high-fat diet. 14 High-carbohydrate meals are known to boost levels of serotonin: insulin produced in response to carbohydrate consumption lowers the blood levels of large neutral amino acids, which compete with tryptophan to pass through the blood-brain barrier. This results in a higher brain concentration of tryptophan, the precursor of serotonin, which induces a calming effect. 15 Whey protein, which is rich in large neutral amino acids, has a similar effect. 16 The suggestion that protein be emphasized at breakfast and lunch while complex carbohydrates should be emphasized in the evening to promote sleep is based on the observation of the calming effects of carbohydrates. However, because glucose tolerance is lower at night, simple carbohydrate intake may result in excessive insulin production and higher blood glucose levels, which will be particularly problematic for patients with impaired glucose tolerance or type 2 diabetes. Complex carbohydrates induce a more moderate insulin response and would thus be more suitable than simple carbohydrates. Whey protein might also be used to promote this calming influence if carbohydrate intake might be problematic. The suggestion of protein intake at breakfast and lunch takes advantage of the tyrosine content of most proteins. Elevating tyrosine concentration in the brain stimulates catecholamine synthesis, 17 which may give cancer patients increased energy for activity during the day. High-tyramine foods similarly result in catecholamine synthesis.
Additional suggestions concern herbal teas and supplements that should be emphasized or avoided during the day or during the evening. We have previously reviewed the subject of herbs and sleep. [18] [19] [20] American ginseng recently showed promising results in a study of cancer-related fatigue. 21 Accumulating evidence suggests that several of the available herbs and supplements may be useful to promote sleep; additionally, a recent trial suggests that melatonin may be a useful sleep aid in the elderly. 22 
Lifestyle Interventions: Exercise and Physical Care
The exercise and physical care area of lifestyle interventions includes exercise prescriptions and modification of the environment to promote health and basic sleep hygiene. Table 2 shows basic recommendations for using exercise and physical care to reset a disrupted circadian rhythm or help strengthen normal rhythms in patients who are under stress. Exercise itself has significant potential to improve outcomes in cancer patients. Breast cancer and colon cancer patients who walk 3 to 6 hours per week cut their mortality risk by half, according to cohort studies. A randomized trial of exercise during high-dose chemotherapy and bone marrow transplant found that patients who used an exercise bike for 30 minutes daily had less pain, neutropenia, diarrhea, thrombocytopenia, and fewer hospital days than control patients who did not exercise. 23 Although intervention studies in this area are just beginning, a randomized trial in nursing home patients found that a sleep intervention lasting 5 days, consisting of efforts to decrease daytime sleep, 30 minutes or more of daily sunlight exposure, increased physical activity, structured bedtime routine, and efforts to decrease noise and light at night resulted in a significant difference in time awake at night, a reduction in daytime sleeping, and an increase in daytime social and physical activity. 24 Results from such a brief intervention suggest that longer-term, concerted effort could modify the daily sleepactivity rhythm.
Whereas several of the suggestions in Table 2 are consistent with typical sleep hygiene practices, others need some review. The study above indicates daytime sunlight exposure as one of the methods of sleep intervention. Additionally, a study in breast cancer patients undergoing chemotherapy found that patients who were more fatigued were likely to report less sunlight exposure. Whether the fatigue was because of lack of light, or fatigued patients were less likely to go outside, is not clear. 25 Bright light exposure at the beginning of the night, along with attenuation of light (sunglasses) in the morning, was found to aid shift workers in maintaining alertness at night while sleeping during the day. 26 There is substantial evidence that bright light exposure can shift circadian rhythms, although validated treatment regimens are not well developed. 27 A study of persons with primary insomnia, for instance, found no difference in subjective or objective sleep parameters with exposure to bright or dim light in the evening or morning, even though the circadian phase was predictably shifted. 28 Bright light in the evening was found to alleviate sleep maintenance insomnia in healthy elderly people, however. 29 These studies together suggest that morning exposure to bright light, together with a brief evening period of bright light in some cases, would be helpful to those with disrupted circadian rhythms, whereas lights should be dimmed in the final hour or so before bed.
Moderate aerobic exercise has been shown to improve sleep quality, latency, and duration in older adults with moderate sleep complaints in a randomized study of community-based exercise. 30 Exercise has also been shown to phase shift circadian rhythms: night shift workers who exercised for short periods every hour were found to have large temperature rhythm phase delay shifts, whereas controls did not show such shifts. 31 Exercise done at the beginning of normal sleep time delayed normal dim-light melatonin onset in both elderly and young participants. 32 Those who exercised during their biological night were found to have significant changes in melatonin rhythm even though they were maintained constantly in dim light during the experimental period, demonstrating that exercise was indeed the cause of the change in circadian rhythm and not the normal day-night lighting cycle. 33 Thus, cancer patients with circadian disruption may be counseled to exercise moderately during the day to both improve sleep quality and maintain melatonin secretion during the night. Exercise at the beginning of normal sleep time should be avoided. Table 3 shows basic recommendations for using the methods of mind-body medicine to reset disrupted circadian rhythm or help strengthen normal rhythms in patients who are under stress. The techniques of mind-body medicine overlap somewhat with those of physical care because counseling interventions to improve sleep may include sleep hygiene methods. However, the mind-body interventions have a stronger focus on relaxation, meditation, and cognitive-behavioral methods. Besides altering sleep-related behaviors, these methods have physiological impacts. A study of mindfulness meditation compared 8 women who performed meditation with 8 who did not. The meditators had significantly higher 12-hour urinary production of 6-sulphatoxymelatonin than the nonmeditators. The effect was significantly stronger for those who had been meditators for a longer period. 34 Increases in melatonin after training in meditation were noted by Harinath et al, 35 Solberg et al, 36 and Tooley et al. 37 Carlson et al 38 did not find increases in melatonin with meditation training in cancer patients but did observe a tendency toward normalization of the abnormal cortisol secretion pattern observed at baseline. The intervention studies involving mind-body methods have generally involved sleep quality rather than circadian variables per se. Thus, Berger et al 39 developed a sleep promotion plan for breast cancer patients receiving chemotherapy. The plan included modified stimulus control, modified sleep restriction, relaxation therapy, and sleep hygiene. Controls received healthy eating information and attention. Sleep quality and night wakening, duration awake, and sleep efficiency were better in the sleep intervention group, although cancer-related fatigue was not altered by the intervention. A cognitive-behavioral therapy intervention for breast cancer survivors, who often suffer from sleep problems as well as fatigue, resulted in improvement in fatigue, quality of life, and anxiety and depression. 40 A cognitive-behavioral intervention was also effective in improving sleep in patients receiving peritoneal dialysis. 41 Tibetan yoga, which has a strong meditative component, was found to improve sleep quality in lymphoma patients. 42 Disturbed sleep and abnormal rest-activity patterns may also contribute to depression and anxiety in lung cancer patients, suggesting that circadian interventions could be used to improve depression in these patients. 43 Mind-body medicine techniques, as noted in these studies, may contribute to improving sleep quality, which may help reinforce normalized circadian rhythms, although there are few studies and thus limited evidence of this at present.
Lifestyle Interventions: Mind-Body Medicine
Biology
The Cancer Terrain: Cancer's Biochemical Milieu and Its Interaction With Circadian Biology
The term terrain has been used by other authors to describe the cancer-promoting internal milieu or environment-a spatially diverse internal landscape in which various physical and biochemical factors enhance or depress the growth and metastasis of cancer cells. 44 These factors can act in much the same way in which limiting factors can slow the growth of plant or animal populations. Figure 4 represents the 6 terrain factors of inflammation, oxidation, immune dysregulation, insulin-IGF axis, coagulopathy, and stress chemistry as they influence the biochemical milieu. Figure 5 represents the consequent effect of the biochemical milieu on processes associated with cancer. Although the terrain factors may seem remote from the biology of circadian rhythms, each of these factors is in fact linked to aspects of circadian rhythms that ultimately may affect the health of cancer patients. This section will outline how each of the 6 terrain factors relates to cancer growth, methods of assessment and treatment relevant to each factor, and how disrupted circadian rhythm may result in abnormal levels of terrain factors-or, conversely, how disrupted terrain factors may influence overall circadian rhythm.
Inflammation. The influence of inflammation on cancer has been studied for years: it is well known that inflammatory prostaglandins promote growth of cancer cells, in addition to involvement in disease complications and impaired quality of life. 45 In one of the most recent investigations of the effects of inflammation on cancer, Pierce et al 46 determined levels of serum amyloid A and C-reactive protein (CRP), both of which are markers of inflammation, in nearly 2000 breast cancer patients. Patients with the highest serum amyloid A had a significantly higher mortality risk than those with the lowest level (HR = 3.51); those with the highest CRP levels also had significantly elevated mortality risk (Hazard Ratio; HR= 2.27). 46 Inflammation is assessed by several common blood tests, among them CRP and fibrinogen; interleukin-6 (IL-6) and nuclear factor (NF)-kB are others. Although very elevated levels of inflam mation with clinical symptoms may be addressed medically through the use of NSAIDs and COX-2 inhibitors, lifestyle adjustments and supplementation can be important as well. An anti-inflammatory diet is low in omega-6 fatty acids and arachidonic acid from seed oils such as corn oil and from meats, respectively; rich in whole grains, vegetables, and fruits; and lacks refined carbohydrates. Dietary supplements may be advised, including fish oil, boswellia, turmeric, tart cherries, mixed tocopherols, and other anti-inflammatory elements. 37, 47, 48 Vgontzas and Chrousos 49 discuss the circadian dynamics of the inflammatory markers IL-6 and tumor necrosis factor-a (TNF-a). Elevated levels of cytokines are associated with fatigue and sleepiness and may be important in cancer-related fatigue. 50 IL-6 has been shown to be somnogenic in several animal species. IL-6 secretion normally undergoes 2 zeniths at 17:00 to 19:00 hours and at 05:00 hours. In chronic insomnia and some other sleep disorders, this pattern is disrupted, and zeniths are found in the midafternoon and early evening. TNF-a also shows a circadian rhythm that is disrupted in insomniacs. Overall levels of IL-6 and TNF-a are elevated after sleep restriction, and high levels of these cytokines are associated with excessive daytime sleepiness in some disorders. We propose using a diet and supplementation strategy to decrease IL-6, 51 along with lifestyle counseling, including sleep hygiene to promote sufficient nighttime sleep, as a way to reduce cytokine levels that may contribute to cancer-related fatigue as well as disease progression.
Oxidation. Free radicals play important roles at all stages of cancer, beginning with free radical injury to DNA as a basic step of carcinogenesis. Breast cancer patients with higher levels of plasma carotenoids, important food-supplied antioxidants, were found to have better overall survival in a recent study. 52 Oxidation is assessed clinically with several tests, including lipid peroxides and oxidized LDL cholesterol. Circadian rhythms in markers of oxidative stress were observed in nondiabetic and Type 2 diabetic men. Serum uric acid and nitrite concentrations had a significant circadian rhythm in nondiabetic, but not in diabetic men, as did urinary 8-hydroxydeoxyguanosine (a marker of oxidative DNA damage). Peak levels of the urinary oxidative stress markers and serum nitrite occurred in the early evening, likely because of increased metabolism after meals. 53 The plasma antioxidants glutathione and cysteine undergo cyclic oxidation and reduction that also appear to have circadian rhythms that are likely correlated with meal times. 54 A complex network of endogenous and exogenous antioxidants modulate the degree of oxidative protection in the body. Many of the antioxidants are supplied by food. To the extent that oxidative stress is correlated with meal times, antioxidants taken at meals may reduce oxidative damage, reinforcing the need for vegetables and fruit in the diet.
Immunity. Disturbances in circadian rhythm, particularly those occasioned by disrupted sleep patterns such as shift work, are known to suppress immune function, resulting in higher levels of cancer-stimulating cytokines. 55 The increased cancer risk for shift workers may be related in part to this immune suppression and elevated cytokine level. Aspects of immune function, particularly natural killer (NK) cells, also contribute to survival outcomes in cancer. 56 The suppression of the immune system during chemotherapy, leading to neutropenia and possibly infections, is also an important dynamic of the immune system during cancer. Immune status can be measured with clinically available tests, including the complete blood count and NK cell cytotoxicity. Overall levels of immune function can be improved through healthy diet and exercise, minimizing stress and alcohol consumption, and supplements, particularly the herb Astra galus membranaceus and mushrooms such as Lentinula edodes and Ganoderma lucidum. [57] [58] [59] It is clear that multiple aspects of the immune system are under circadian control. Interferon-g, for instance, has a circadian rhythm under the control of the clock gene mPer2; the function of NK cells also has a circadian rhythm. 60.61 The circadian rhythm of regulatory T cells is disrupted by lack of sleep. 62 Because of the apparent link between sleep and disturbance of immune function, an obvious initial area of intervention for immunity would be to institute a healthy daily rhythm of sleep and activity.
Insulin-IGF axis. Awareness of the potential of the insulin-IGF axis and elevated blood sugar to worsen cancer outcomes has grown in the past few years. Higher fasting insulin levels were associated with worse outcomes in early-stage breast cancer patients, and insulin as well as IGF are thought to promote cancer. 63, 64 Standard tests for insulin and blood sugar levels can be used to assess potential abnor malities. Interventions to normalize insulin and IGF levels include reducing weight; increasing exercise; a diet low in fat, sugar, and animal foods and high in fiber and monounsaturated fats; oral antidiabetic medications; and supplements such as chromium, coffeeberry, cinnamon, and bitter melon. Timing of meals in relation to insulin secretion, insulin resistance, and glucose tolerance is discussed above.
Coagulopathy. It has been known for some time that platelet activation and markers of elevated plasma viscosity can predict survival in cancer patients. [65] [66] [67] In addition, markers such as elevated fibrinogen are associated with poor response to chemotherapy. 68, 69 Cancer patients are also at risk for complications caused by thrombi. Assessments for coagulation risk factors include fibrinogen, homocysteine, and other clinically relevant measures. Interventions to adjust for abnormalities in coagulation include supplements such as bromelain, garlic, ginger, enzyme products, and others, in addition to reducing fat intake and dairy products and including flavonoid-rich vegetables and fruits in the diet. A circadian rhythm in platelet aggregation has been cited as a cause for the increase in myocardial infarction, sudden cardiac death, and fatal pulmonary thromboembolisms between 6 am and noon. 70, 71 Coagulation is also highest, whereas fibrinolysis is lowest, in the morning. 72 The knowledge that clinically significant peaks in blood coagulation occur provides special impetus to the use of diet, medication, and supplements to normalize these parameters in cancer patients who are at elevated risk for thrombi.
Stress chemistry. Breast cancer patients who had abnormal cortisol rhythms had worse NK cell activity and shorter survival times. 73 Surgical patients who have high levels of anxiety and cortisol tend to have more difficult recovery from surgery. 74 Stress chemistry may also influence chemotherapy: patients who had low psychospiritual scores prior to chemotherapy were more likely to have altered rhythms of cortisol secretion, experience lymphocytopenia during chemotherapy, and experience reduced efficacy of chemotherapy. 75 Salivary cortisol levels are a basic assessment for stress chemistry; actigraphy can also be used clinically to detect altered circadian rhythm of activity. Normalization of the cortisol rhythm is dependent in part on normalization of the circadian rhythm, so interventions discussed above under exercise and physical care as well as mind-body medicine are relevant. An additional area of intervention is in lowering overall psychological stress levels, which may contribute to poor sleep. Resistance to stress may be helped by adaptogenic herbs such as Siberian and Asian ginsengs, 76 licorice, or Rhodiola rosea. 77 Herbs and supplements with calming effects, to be taken before bed, include melatonin, the green tea constituent l-theanine, 78 and mimosa bark. 79
Treatment
Circadian Rhythms and Cancer Treatment
A goal of integrative cancer treatment is to assist patients in tolerating their conventional treatment regimens. Patients who do not complete their full planned chemotherapy regimens have been noted to have significantly shorter survival than those completing full regimens. 80, 81 One means of aiding patients in completing their regimens is through chronomodulation of chemotherapy cycles. This topic has been reviewed extensively elsewhere. [82] [83] [84] Integrative care involving lifestyle and supplements may also contribute to improving toleration of chemotherapy regimens, as noted above.
There is a category of lifestyle interventions, however, that is tailored more directly to patients going through chemotherapy, along with debilitated patients who have advanced cancers or cachexia. These interventions are summarized in Table 4 . Chemotherapy places patients in a situation of nutritional stress. Patients with cachexia are also obviously in a situation of nutritional stress. Thus, they can be advised to shift to foods that present more concentrated nutrition without including unhealthful elements such as sucrose, refined flour, transfats, or saturated fats. Additionally, the suggestions for circadian-sensitive timing of meals should be adjusted for this patient population. A major difficulty during chemotherapy or for debilitated patients is anorexia. Appetite is generally low, with the exception of the morning, when appetite may be better. Consequently, the largest meal of the day needs to be moved to breakfast, whereas the other meals are divided into several snacks, resulting in a "grazing" pattern. Supplements of proteins or medium-chain triglyceride oil 85 can assist in raising caloric and protein 
Dietary guidelines
Increase caloric and nutritional density of diet: use calorically dense foods, including healthful concentrated carbohydrate sources, lower dietary fiber, and increased proteins (including fish, egg whites, l-glutamine, chlorella supplements, and whey protein) Increase intake of omega-3 rich oils, medium-chain triglyceride oil, and to a lesser extent, omega-6 rich oils Adjust meal schedule to a grazing pattern of 6-8 meals daily Shift largest meal of the day to breakfast, when appetite may be best Supplement with whey protein, soy protein, and medium-chain triglyceride shakes For cachexia, use anti-inflammatory supplements (curcumin, fish oil, boswellia, scutellaria) Exercise guidelines
Reduce aerobic exercise emphasis Emphasize interval training (repeated short sessions of aerobic-type exercise) Emphasize strength or resistance training (use light weights or isometrics; short sessions repeated several times daily) Emphasize systems such as yoga, Pilates, qi gong, or tai chi that increase flexibility Do not overexercise, because this produces inflammation and increases cortisol intake; protein intake can be quite critical as albumin levels have been shown to have prognostic value in several cancers. 86 Additionally, because cancer cachexia appears to be stimulated by inflammatory cytokines, 87 use of antiinflammatory herbs and supplements is warranted. Alteration of exercise patterns is also needed. Although aerobic exercise is recommended for patients who are not going through treatment and for breast and prostate cancer patients who are overweight, patients in treatment and patients affected by cachexia need a strategy that deemphasizes aerobics. Strength (weight) training and also exercise modalities that emphasize stretching, flexibility, and controlled movement are better suited to patients who need to build muscle mass rather than to lose weight. Animal data remind us, additionally, that there may be larger-scale rhythms beyond the circadian rhythm that affect cancer growth. Specifically, a circannual rhythm in postresection pulmonary metastases in mice bearing implanted mammary tumors was observed over a 14-year period in 22 separate experiments. The probability of metastasis was significantly higher in mice that received surgery in the summer and winter than those resected in spring or fall. 88 
Combining Integrative Lifestyle Therapy With Chronomodulated Chemotherapy
An observational study of chronomodulated chemotherapy was recently completed at the Block Center for Integrative Cancer Treatment. Patients with histologically confirmed stage III or IV colorectal carcinoma treated with a chronomodulated chemotherapy schedule from 1999 to 2005 were eligible for this case series, chart review study. These patients also received counseling in an integrative lifestyle intervention consisting of an anti-inflammatory diet, supplementation individualized according to laboratory testing results as well as clinical needs and problems, exercise adapted for clinical conditions, and mind-spirit counseling, including encouragement of good sleep hygiene. The study was conducted between June and August, 2005. Outcome data were updated in June, 2009. There were no other inclusion or exclusion criteria. A convenience sample of cases was obtained, consisting of charts that had previously been located for a preliminary chronotherapy assessment and of patients who visited the office for treatment or follow-up during the study period. Data collected for the study included radiology, laboratory, and pathology reports. Data on metastases were extracted from bone scans, CT scans, MRIs, X rays, pathology, and consultation reports. Medical chart notes that detailed chemotherapy toxicities and supplements recommended to patients were also used. The study was approved by the University of Illinois at Chicago's Institutional Review Board. Demographics and treatments. Table 5 shows the characteristics of patients. Of 35 colon cancer cases obtained, 26 patients fit inclusion criteria. Of these, 6 patients had stage III and 20 had stage IV cancer. The most common metastatic sites were liver and multiple sites. Of the stage IV patients, 8 presented for first-line treatment, whereas 12 presented for second-line or later therapy. All patients had undergone colon resections, whereas 3 had had liver resections for isolated metastases. A total of 525 chemotherapy treatments were administered to the 26 patients. The most common chronomodulated chemotherapy regimens administered were FOLFIRI (irinotecan, continuous and bolus 5FU, and leucovorin) and FOLFOX (oxaliplatin, continuous and bolus 5FU, and leucovorin) regimens, as recommended by the Center's oncology staff. All patients received supportive medications prior to chemotherapy treatments, which included dolasetron, atropine, ondansetron, dexamethasone, prochlorperazine, loperamide, and diphenhydramine as indicated by individual circumstances. Pretreatment was based on drugs administered and side effects from previous chemotherapy. Because approximately 70% of patients visited the center from out-of-state locations, patients frequently received colony-stimulating factors to prevent hematological toxicities and decrease the risk of neutropenic infections after completing a cycle of treatment at the center. Supplements recommended for all patients included fish oil and a multivitamin and mineral supplement designed for cancer patients. Patients received prophylactic treatment with l-glutamine for mucositis and peripheral neuropathy. a-Lipoic acid and vitamin B6 were also recommended to decrease peripheral neuropathy. All patients received an intravenous antioxidant and nutrient infusion during chemotherapy to prevent nutrient deficiencies. Other supplements were recommended for patients based on individual testing and clinical concerns.
Rechallenged patients. Twelve patients had previously received a variety of regimens, which included continuous infusion chemotherapies, but were unable to tolerate them because of grade 3 to 4 toxicities; this included 2 patients hospitalized for side effects. Five of these patients had received multiple chemotherapy regimens prior to the continuous regimens in question. The 12 patients were then rechallenged at the center with chronotherapeutically administered adaptations of either the same regimen or more intensive regimens. Drugs added to prior regimens included bevacizumab, irinotecan, and oxaliplatin. Table 6 contrasts the side effects experienced by this group on continuous therapies with the side effects of the chronomodulated regimens. No grade 3 to 4 toxicity and no hospitalization was observed with the chronotherapy regimens. The rechallenged patients included 2 stage III patients who received additional cycles of adjuvant therapy at the block center because they were unable to tolerate continuous infusion therapy at other centers. Among the 10 stage IV patients, outcomes for chronotherapy were 1 complete response, 4 stable disease (growth less than 25% or shrinkage less than 50%), and the remainder progressive disease. Median survival of the entire rechallenged group from the start of chronotherapy treatment was 26 months, and median survival of stage IV patients was 17 months. Two rechallenged patients are still living at this time, 71 and 88 months after diagnosis.
Toxicity. In the entire patient population, the most widespread grade 1 to 2 toxicities were nausea and fatigue (Table 7) . Grade 1 to 2 diarrhea or constipation was experienced by 35% of patients; frequent, severe diarrhea is a common side effect of irinotecan. Grades 1 to 2 mucositis and neuropathy were experienced by 15% of patients: mucositis is common with 5FU, whereas paresthesias are common with oxaliplatin administration. Four patients experienced grade 3 toxicity, 1 patient experienced grade 3 diarrhea, and none experienced grade 3 mucositis or paresthesias. In the entire population, 6 patients had dose reductions, some for grade 2 toxicities. Five of these patients were receiving FOLFIRI regimens. No grade 4 toxicity was observed. Two patients on FOL-FIRI tolerated dose increases without complaints.
In comparison, Tournigand et al 89 Figure 6 shows the Kaplan-Meier survival curve for this group. Median overall survival of the stage IV group is 28 months.
These outcomes appear advantageous compared with those in the literature, although the population observed is small. The most common regimen used by patients in this sample was FOLFIRI. Reports of overall survival for patients in studies of nonchronomodulated FOLFIRI in metastatic and advanced colorectal cancer include 16.6 months (Skof et al), 92 18.6 months (Santoro et al), 93 14 months (Colucci et al), 94 16 .7 months (Falcone et al), 90 19 .5 months (Souglakos et al), 91 and 21.5 months (Gluzman et al). 95 Severe toxicities are lower than those in other studies. Some toxicity control may be partly because of supplements administered. The lower toxicity rate suggests potentially better treatment tolerance and fewer treatment dropouts. Rechallenged patients who had previously experienced severe toxicity tolerated similar or more intensive regimens using chronotherapy without grade 3 to 4 toxicity. Further research on the promising combination of chronotherapy and integrative therapy for colon cancer should be pursued.
Conclusion
Chronobiology plays a role in each of the aspects of cancer treatment discussed in this article. Lifestyle modification offers an avenue to assist in resetting disrupted circadian rhythms. The timing and types of foods should be attuned to circadian rhythms of sleep and waking as well as rhythms of secretion of insulin. Diet composition can stimulate or depress cortisol output and wakefulness and should thus be different during the day and the night. Exercise during the day or early in the evening, rather than at the start of the sleep period, can help reinforce normal rest-activity cycles. Exposure to the sun early in the morning may additionally help entrain circadian rhythms for those whose secretion of melatonin is phase shifted. Mind-body medicine, including meditation and yoga, in addition to cognitive-behavioral programs of sleep hygiene, contributes to normalizing restactivity cycles. The lifestyle recommendations are somewhat modified, though, in the case of patients with advanced cancer who are experiencing cachexia or cancer-induced weight loss. In this case, eating patterns need to be adjusted so that the largest intake is timed during the morning when appetite is strongest, with a "grazing" pattern of meals during the rest of the day to maximize food intake.
The internal biochemical milieu or cancer terrain affects and is affected by chronobiological rhythms. Inflammation, oxidation, immunity, coagulation, insulin-IGF axis, and stress hormone secretion all have potential impact on cancer growth as well as quality of life, ability to respond to and tolerate conventional treatment, and resistance to disease complications. Inflammation affects levels of IL-6, associated with daytime sleepiness, and efforts to control inflammation through diet, supplements, and medications may aid in resetting the circadian clock. Rhythms of oxidation and reduction are often linked to food intake patterns. Some aspects of immune function are controlled physiologically and have been linked to clock genes. However, lack of sleep disrupts immune functioning, and efforts to improve sleep patterns may benefit immune variables. The known rhythm of insulin secretion suggests timing of meals, and attempts to lower overall insulin secretion may contribute to cancer control. Blood coagulation is known to have circadian patterns with a large peak in the morning that has been linked to morning peaks of myocardial infarction. Finally, the pattern of elevated morning cortisol and lower evening cortisol levels was found to correlate with breast cancer outcomes. Lifestyle interventions to reinforce normal rest-activity patterns and promote healthful sleep may aid in regulating cortisol timing. Additionally, efforts to decrease stress may improve sleep through decreasing the anxiety that may keep patients awake during nighttime hours.
In the area of treatment, chronomodulation of chemotherapy may improve outcomes and decrease the toxicities of conventional treatment. Decreasing toxicities can promote the ability of patients to tolerate full prescribed chemotherapy regimens. This subject has been reviewed elsewhere, but a brief account of patients receiving chronomodulated chemotherapy along with an integrative lifestyle regimen demonstrates reduction in toxicities and an apparently more favorable survival outcome than expected. The relevance of circadian rhythms to cancer biology, described elsewhere in this special issue, suggests that efforts to normalize circadian rhythms of sleep and activity through lifestyle intervention may be relevant to improving cancer outcomes. We have developed a comprehensive cancer treatment and lifestyle intervention for cancer patients with disrupted circadian rhythms or poor sleep patterns, and we suggest that it should be piloted in clinical populations, with a goal of eventually conducting randomized trials. This article presents suggestions for such lifestyle interventions and could be used as a foundation for developing a clinically testable model.
